Cisplatin Injection: Cisplatin Injection BP 50 mg/50 mL is a prescription platinum-based cytotoxic chemotherapy medicine supplied as a sterile intravenous solution containing cisplatin at a concentration of 1mg per mL. It is administered only in hospitals or specialised oncology centres by professionals experienced in cancer chemotherapy. Product Specification Product Detail Specification Generic name Cisplatin Pharmacopoeial standard BP Dosage form Sterile injection solution Strength 50mg/50mL Concentration 1mg/mL Route of administration Intravenous infusion Therapeutic class Platinum-based antineoplastic medicine Appearance Clear, colourless to pale-yellow solution Primary users Hospitals, oncology centres and cancer institutes Supply category Prescription-only institutional medicine Therapeutic Applications Treatment selection, infusion schedule and total dose must be determined individually. Cisplatin must not be presented as suitable for self-treatment or direct unsupervised administration. What Special Precautions Should I Follow? Kidney monitoring: Cisplatin can cause severe cumulative renal toxicity. Kidney function and electrolyte levels should be checked before and during therapy. Adequate hydration: Intravenous fluids may be required before, during or after treatment to reduce renal complications. Blood testing: Complete blood counts are monitored because cisplatin can suppress bone-marrow function. Hearing assessment: Report tinnitus, reduced hearing or balance problems promptly. Nerve symptoms: Tingling, numbness or weakness should be communicated to the treating physician. Infection or bleeding: Seek medical advice for fever, unexplained bruising or unusual bleeding. Pregnancy prevention: Cisplatin may harm an unborn baby; effective contraception may be required. Vaccinations: Live vaccines should not be received without approval from the oncology specialist. Cisplatin Injection BP 50mg/50mL supplier Buy Cisplatin Injection in Kingston Jamaica Cisplatin Injection supplier Indonesia Cisplatin 50mg exporter from India Cisplatin Injection wholesale price Platinum chemotherapy medicine supplier Cisplatin oncology injection distributor Anti-cancer injection exporter India Cisplatin bulk supplier for hospitals Cisplatin Injection importer Jamaica Oncology medicine supplier Jakarta Generic Cisplatin Injection manufacturer Hospital chemotherapy procurement supplier Cisplatin 1mg/mL injection exporter Cancer medicine distributor in Jamaica Oncology drug supplier in Indonesia GMP oncology medicine exporter Cisplatin institutional supply India Short FAQs 1. What is Cisplatin Injection 50mg/50mL used for? It is a platinum-based chemotherapy medicine used for selected cancers, including advanced testicular, ovarian and bladder cancers. 2. Can Cisplatin Injection be administered at home? No. It must be prepared and administered intravenously in a properly equipped medical facility by trained professionals. 3. Why is hydration important during cisplatin therapy? Adequate hydration helps reduce the risk of cisplatin-related kidney damage. 4. Is Cisplatin Injection available for export to Jamaica and Indonesia? Supply may be arranged for licensed importers and approved healthcare institutions, subject to each country’s registration, prescription-drug and customs requirements. 5. Which documents may institutional buyers request? Common requirements may include a Certificate of Analysis, batch details, commercial invoice, packing list, certificate of origin and applicable manufacturing or regulatory certificates. 🌍 Ernest Oncology | Global Oncology Medicine Export Solutions [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Global Pharmaceutical Exporter 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 #CisplatinInjectionBP #Cisplatin50mg50mL #PlatinumOncologyTherapy #HospitalChemotherapySupply #KingstonCancerCare #JamaicaOncologyImport #IndonesiaOncologyMarket #JakartaMedicineSupply #CytotoxicInjectionExporter #SolidTumourTreatment #CancerInstituteProcurement #OncologyVialSupplier #InstitutionalCancerMedicine #SterileChemotherapyInjection #PlatinumDrugDistribution #GlobalOncologySourcing #CancerHospitalSupplyChain #IndianOncologyExporter #SpecialisedMedicineLogistics #CisplatinBulkProcuremen

CISLIEVA 50 MG Injection (Cisplatin): High-Strength Platinum Therapy for Comprehensive Oncology Care CISLIEVA 50 MG Injection is a potent, high-dose antineoplastic medication featuring the active pharmaceutical ingredient cisplatin. As a foundational first-generation platinum-based chemotherapeutic agent, it is globally recognized for its efficacy in treating various aggressive solid tumors. Manufactured under stringent WHO-GMP guidelines, CISLIEVA 50 MG is designed to deliver a high concentration of the active agent, making it a critical tool for oncologists managing complex cancer treatment protocols. Therapeutic Indications and Global Clinical Usage Metastatic Testicular Cancer: Used in established combination therapies for patients who have undergone appropriate surgical or radiotherapeutic intervention. Advanced Ovarian Cancer: Indicated as first-line therapy in combination with other agents, or as secondary therapy for patients who have failed prior treatment. Advanced Bladder Cancer: Utilized for transitional cell carcinoma that is no longer responsive to localized treatment. Lung Cancer: Frequently used in combination cycles for both Small Cell Lung Cancer (SCLC) and Non-Small Cell Lung Cancer (NSCLC). Head and Neck Cancers: A key component in chemo-radiation protocols for squamous cell carcinomas. Cervical and Esophageal Cancers: Effective in systemic regimens for advanced or metastatic disease. Mechanism of Action: How CISLIEVA 50 MG Works Cellular Activation: After entering the cell, the molecule becomes a highly reactive, positively charged platinum complex. DNA Binding: The complex binds to the DNA of the cancer cell, specifically targeting the guanine and adenine bases. Cross-Link Formation: It creates intra-strand and inter-strand cross-links, effectively “pinning“ the DNA strands together. Replication Interference: These cross-links distort the DNA helix, preventing it from unwinding—a process essential for DNA replication and protein transcription. Apoptosis: The cell recognizes this irreversible damage and triggers programmed cell death (apoptosis), leading to tumor shrinkage and prevention of further metastasis. Professional Administration & Safety Protocols Route of Administration: Strictly via Intravenous (IV) Infusion. Vigilant Hydration: To prevent nephrotoxicity (kidney damage), patients must receive pre-treatment and post-treatment hydration (usually 1-2 liters of fluids) along with diuretics like mannitol. Clinical Monitoring: This high-strength injection must be administered by trained oncology teams in environments equipped for close patient monitoring. Electrolyte Management: Serum levels of magnesium, potassium, and calcium must be monitored and supplemented as necessary during treatment. Safety Profile and Clinical Oversight Nephrotoxicity: Frequent checks of BUN and serum creatinine levels are mandatory. Ototoxicity: Periodic hearing tests are recommended, as Cisplatin can cause permanent hearing impairment. Myelosuppression: Regular Complete Blood Counts (CBC) are required to monitor for low white blood cell and platelet counts. Neurotoxicity: Vigilance for peripheral neuropathy (numbness or tingling in the hands and feet). Severe Nausea: Aggressive anti-emetic therapy is standard to manage chemotherapy-induced nausea and vomiting (CINV). Why Choose Ernest Oncology? 100% Genuine Medication: We source directly from GMP-certified channels, ensuring product authenticity and optimal shelf life. Verified Global Export Network: We facilitate rapid and secure shipping to the USA, UK, UAE, Australia, Singapore, South Africa, Europe, Middle East, Africa, and Asia. Regulatory & Documentation Support: Our team handles all necessary paperwork, including Certificates of Analysis (CoA) and permits, ensuring smooth customs clearance. Logistics Precision: We utilize secure, pharmaceutical-grade packaging and efficient transit routes to maintain product stability during international transit. Bulk Supplier Advantage: As a dedicated distributor, we offer competitive wholesale rates to support oncology hospitals, clinics, and government health departments worldwide. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct WhatsApp Connection

CISLIEVA 10 MG Injection (Cisplatin): A Fundamental Platinum-Based Therapy for Precision Oncology CISLIEVA 10 MG Injection is a highly potent antineoplastic agent featuring the active pharmaceutical ingredient Cisplatin. As a first-generation platinum-based chemotherapeutic agent, Cisplatin remains one of the most effective and widely utilized drugs in the global fight against various solid tumors.. The 10mg dosage is a critical strength used for precise titration, allowing oncologists to design customized treatment cycles that balance therapeutic efficacy with patient safety. Therapeutic Indications and Clinical Scope Metastatic Testicular Tumors: A primary component of combination therapy in patients who have already received appropriate surgical or radiotherapeutic procedures. Metastatic Ovarian Tumors: Indicated as secondary therapy in patients who have already received but failed standard chemotherapy, or as a first-line agent in combination with other approved drugs. Advanced Bladder Cancer: Used as a single agent or in combination for patients with transitional cell bladder cancer that is no longer amenable to local treatments. Head and Neck Cancers: Frequently employed in chemotherapy regimens for squamous cell carcinomas of the head and neck. Cervical Cancer: Used in conjunction with radiation therapy or other chemotherapeutic agents for advanced stages. Mechanism of Action: How CISLIEVA 10 MG Works Cellular Entry: Once the drug enters the cell, it loses its chloride atoms and becomes a positively charged molecule. DNA Binding: The activated platinum complex binds to the nitrogen atoms of the DNA bases (specifically guanine and adenine). Intrastand Cross-Linking: It creates “kinks“ or cross-links within the DNA strands. Inhibition of Synthesis: These structural changes make it impossible for the DNA to unwind or replicate. Programmed Cell Death: The DNA damage triggers a cellular response that leads to apoptosis (programmed cell death), halting tumor growth and preventing metastasis. Professional Administration and Safety Guidelines Route: Administered strictly via Intravenous (IV) Infusion. Hydration Protocol: To minimize the risk of nephrotoxicity (kidney damage), patients must receive adequate pre-treatment and post-treatment hydration (usually 1 to 2 liters of fluid). Clinical Environment: This medication must be administered by trained oncology professionals in a setting equipped for continuous monitoring. Precise Titration: The 10mg strength facilitates accurate dosing for pediatric cases or for patients requiring gradual dose escalation . Safety Profile and Professional Monitoring Nephrotoxicity Monitoring: Regular monitoring of serum creatinine, BUN, and creatinine clearance is mandatory. Ototoxicity Checks: Patients should undergo periodic hearing tests (audiograms), as Cisplatin can cause cumulative and permanent hearing loss. Hematological Vigilance: Regular Complete Blood Counts (CBC) are essential to monitor for bone marrow suppression (anemia, neutropenia, and thrombocytopenia). Electrolyte Balance: Monitoring of serum magnesium, potassium, and calcium levels is required to prevent imbalances. Neurotoxicity Monitoring: Vigilance for signs of peripheral neuropathy (numbness or tingling in extremities). Storage and Global Handling Instructions Temperature: Store at controlled room temperature (20°C to 25°C). Do not refrigerate or freeze, as precipitation may occur. Protection: Keep the vial in the original carton to protect it from light. Cytotoxic Handling: As a hazardous antineoplastic agent, CISLIEVA 10 MG must be prepared and handled by trained professionals using appropriate PPE (Personal Protective Equipment) and disposed of according to international biohazard protocols. Why Choose Ernest Oncology? 100% Genuine Medication: We source directly from GMP-certified channels, ensuring every vial is authentic with an optimal shelf life. Specialized Logistics Precision: Our team manages pharmaceutical exports with expertise, utilizing secure packaging and efficient transit routes to maintain product stability. Regulatory & Documentation Support: We handle all necessary paperwork, including Certificates of Analysis (CoA) and export permits, for seamless customs clearance. Bulk Supplier Advantage: As a dedicated distributor, we offer competitive wholesale rates to support oncology hospitals, pharmacy networks, and government health programs worldwide. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct WhatsApp Connection

Platinol Injection (Cisplatin): The Platinum-Based Gold Standard for Advanced Malignancies – Global Supply by Ernest Oncology In the intensive landscape of clinical oncology, Platinol Injection (the brand name for Cisplatin) remains one of the most effective and widely utilized antineoplastic agents. Often referred to as the “penicillin of cancer drugs,“ this platinum-based therapeutic is a cornerstone in both curative and palliative treatment protocols for solid tumors. Its ability to disrupt DNA replication makes it indispensable in multi-drug chemotherapy regimens. Ernest Oncology, the specialized oncology division of Ernest Pharmaceutical Pvt. Ltd., is a leading Exporter, Bulk Supplier, and Distributor from India. We provide high-purity, GMP-certified Platinol Injection to hospital networks and wholesalers in London (UK), the USA, Abu Dhabi (UAE), Australia, and South Africa, backed by 2026-standard global logistics. What is Platinol Injection? (Mechanism & Clinical Role) Platinol is a sterile, aqueous solution for intravenous infusion, typically available in strengths of 10mg, 50mg, and 100mg Vials (1mg/mL concentration). As a bifunctional alkylating-like agent, it is classified as a platinum-coordination compound. Primary Therapeutic Indications Testicular Cancer: Historically the first cancer successfully treated with Platinol; it remains a first-line treatment for metastatic germ cell tumors. Ovarian Carcinoma: Used as secondary therapy for patients refractory to standard chemotherapy or in combination with other agents for advanced-stage cases. Bladder Cancer: Indicated for patients with locally advanced or metastatic transitional cell carcinoma of the bladder who are no longer candidates for local therapy. Other Malignancies: Frequently used in protocols for Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma, and Cervical Cancer. Technical Product Profile: Platinol 1mg/mL Solution Feature Technical Specification Brand Name Platinol / Platinol-AQ Active Ingredient Cisplatin (cis-diamminedichloroplatinum) Pharmacological Class Platinum-Based Antineoplastic / Alkylating Agent Available Strengths “10 mg / 10 mL, 50 mg / 50 mL, 100 mg / 100 mL“ Manufacturer Leading Indian Oncology MNCs (WHO-GMP / USFDA Compliant) Storage Room Temperature (15°C to 25°C); Protect from light; Do Not Refrigerate Mechanism of Action: DNA Cross-Linking Platinol exerts its cytotoxic effects by targeting the DNA within rapidly dividing cancer cells: Activation: Once inside the cell, chloride ligands are displaced by water molecules, forming a positively charged platinum complex. Adduct Formation: These complexes bind to DNA bases, primarily the N7 position of guanine. Structural Disruption: It creates intra-strand and inter-strand cross-links, which bend the DNA and prevent replication, transcription, and repair. This eventually triggers programmed cell death (apoptosis). Clinical Administration & Safety Hydration Protocol: Significant pre-treatment and post-treatment hydration (usually with normal saline) is mandatory to ensure a urine output of at least 100 mL/hour, minimizing the risk of nephrotoxicity. Anti-Emetic Therapy: Due to its high emetogenic potential, modern protocols include aggressive anti-emetic premedication (e.g., 5-HT3 receptor antagonists). Monitoring: Clinicians must monitor Serum Creatinine, BUN, and Magnesium levels before each cycle. Baseline and periodic audiometric testing is required to monitor for cumulative ototoxicity (hearing loss). Incompatibility: Platinol reacts with aluminum; therefore, administration sets containing aluminum components must not be used. Global Supply Chain: London, USA, UAE, Australia, & South Africa United Kingdom & London: Seamless supply to NHS Trusts and London’s private oncology clinics via MHRA-compliant channels. United States: Reliable bulk supply for specialized pharmacies and hospital groups, supporting cost-effective oncology care. Abu Dhabi & UAE: Priority shipping to the Middle East's growing oncology hubs, ensuring rapid availability for government tenders. Australia & South Africa: Strategic distribution to regional wholesalers and health departments, maintaining stable stock levels for critical chemotherapy programs. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India (Group of Ernest Pharmaceutical Pvt. Ltd.) Partner with a verified leader for the bulk procurement of high-quality oncology injectables. 🌐 Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Instant Chat: https://wa.me/919359902383

Cisplatin Injection: The Platinum-Based Gold Standard for Advanced Malignancies – Global Supply by Ernest Oncology In the intensive landscape of clinical oncology, Cisplatin Injection remains one of the most effective and widely utilized antineoplastic agents. Often referred to as the “penicillin of cancer drugs,“ this platinum-based therapeutic is a cornerstone in both curative and palliative treatment protocols for solid tumors. Its ability to disrupt DNA replication makes it indispensable in multi-drug chemotherapy regimens. What is Cisplatin Injection? Cisplatin Injection is a sterile, aqueous solution for intravenous infusion, typically available in strengths of 10mg, 50mg, and 100mg Vials (1mg/mL concentration). As a bifunctional alkylating-like agent, it is classified as a platinum-coordination compound. Primary Therapeutic Indications Testicular Cancer: Historically the first cancer successfully treated with Cisplatin; it remains a first-line treatment for metastatic germ cell tumors. Ovarian Carcinoma: Used as secondary therapy for patients refractory to standard chemotherapy or in combination with other agents for advanced-stage cases. Bladder Cancer: Indicated for patients with locally advanced or metastatic transitional cell carcinoma of the bladder who are no longer candidates for local therapy. Other Malignancies: Frequently used “off-label“ or in clinical trials for Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma, and Cervical Cancer. Technical Product Profile: Cisplatin 1mg/mL Solution Feature Technical Specification Active Ingredient Cisplatin (cis-diamminedichloroplatinum) Pharmacological Class Platinum-Based Antineoplastic / Alkylating Agent Available Strengths “10 mg / 10 mL, 50 mg / 50 mL, 100 mg / 100 mL“ Manufacturer Leading Indian Oncology MNCs (WHO-GMP / USFDA Compliant) Dosage Form Injectable Liquid Solution (IV Use Only) Storage Room Temperature (15°C to 25°C); Protect from light; Do Not Refrigerate Mechanism of Action: DNA Cross-Linking Cisplatin exerts its cytotoxic effects by targeting the DNA within rapidly dividing cancer cells: Activation: Once inside the cell, chloride ligands are displaced by water molecules, forming a positively charged platinum complex. Adduct Formation: These complexes bind to DNA bases, primarily the N7 position of guanine. Structural Disruption: It creates intra-strand and inter-strand cross-links, which bend the DNA and prevent replication, transcription, and repair. This eventually triggers programmed cell death (apoptosis). Clinical Administration & Safety Hydration Protocol: Significant pre-treatment and post-treatment hydration (usually with normal saline) is mandatory to ensure a urine output of at least 100 mL/hour, minimizing the risk of nephrotoxicity. Anti-Emetic Therapy: Due to its high emetogenic potential, modern protocols include aggressive anti-emetic premedication Monitoring: Clinicians must monitor Serum Creatinine, BUN, and Magnesium levels before each cycle. Baseline and periodic audiometric testing is required to monitor for cumulative ototoxicity (hearing loss). Incompatibility: Cisplatin reacts with aluminum; therefore, administration sets containing aluminum components must not be used. Global Supply Chain: London, USA, UAE, Australia, & South Africa Ernest Oncology leverages India’s manufacturing prowess to stabilize the global supply of Cisplatin. We ensure that B2B buyers receive products that meet the stringent 2026 quality benchmarks of international regulatory bodies. United Kingdom & London: Seamless supply to NHS Trusts and London’s private oncology clinics via MHRA-compliant channels. United States: Reliable bulk supply for specialized pharmacies and hospital groups, supporting cost-effective oncology care. Abu Dhabi & UAE: Priority shipping to the Middle East's growing oncology hubs, ensuring rapid availability for government tenders. Australia & South Africa: Strategic distribution to regional wholesalers and health departments, maintaining stable stock levels for critical chemotherapy programs. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India (Group of Ernest Pharmaceutical Pvt. Ltd.) Partner with a verified leader for the bulk procurement of high-quality oncology injectables. 🌐 Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Instant Chat: https://wa.me/919359902383

Celplat 50mg (Cisplatin) Injection Celplat 50 mg Injection contains Cisplatin, a platinum-based chemotherapy medicine used in the treatment of several types of cancers. Cisplatin works by damaging the DNA of cancer cells, preventing them from growing and multiplying. This helps slow or stop the spread of cancer in the body. Cisplatin injections are administered in hospitals or oncology treatment centers under the supervision of qualified healthcare professionals. Ernest Oncology supplies Celplat 50mg (Cisplatin) Injection globally with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Celplat Injection Generic Name: Cisplatin Strength: 50mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Platinum-Based Chemotherapy Packaging Type: Vial Route of Administration: Intravenous (IV) Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Celplat 50mg Injection Celplat (Cisplatin) Injection is used in the treatment of: • Testicular Cancer • Ovarian Cancer • Bladder Cancer • Lung Cancer • Head and Neck Cancer • Cervical Cancer It is often used in combination with other chemotherapy medicines as part of cancer treatment protocols. How Celplat Injection Works Cisplatin works by binding to the DNA of cancer cells, causing damage that prevents them from dividing and multiplying. This helps stop the growth of cancer cells. Administration Celplat 50mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Patient’s body weight • Type and stage of cancer • Treatment protocol • Patient’s overall medical condition The medicine is administered intravenously in hospitals or oncology treatment centers. Possible Side Effects Some patients may experience: • Nausea and vomiting • Fatigue • Kidney problems • Hearing issues • Low blood cell counts • Loss of appetite Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Protect from light • Keep in a cool and dry place • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology — Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Celplat 10mg (Cisplatin) Injection Celplat 10mg Injection contains Cisplatin, a platinum-based chemotherapy medicine widely used in the treatment of various types of cancers. Cisplatin works by damaging the DNA of cancer cells, which stops them from growing and multiplying. This helps slow or stop the spread of cancer in the body. Cisplatin injections are commonly administered in hospitals or oncology treatment centers under the supervision of qualified healthcare professionals. Ernest Oncology supplies Celplat 10mg (Cisplatin) Injection worldwide with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Celplat Injection Generic Name: Cisplatin Strength: 10mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Platinum Chemotherapy Packaging Type: Vial Route of Administration: Intravenous (IV) Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Celplat 10mg Injection Celplat (Cisplatin) Injection is used in the treatment of: • Testicular Cancer • Ovarian Cancer • Bladder Cancer • Lung Cancer • Head and Neck Cancer • Cervical Cancer It is often used along with other chemotherapy medicines as part of combination cancer therapy. How Celplat Injection Works Cisplatin works by binding to the DNA inside cancer cells, causing damage that prevents the cells from dividing and multiplying. This process leads to the destruction of cancer cells and slows tumor growth. Administration Celplat 10mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Patient’s body weight • Type and stage of cancer • Treatment protocol • Patient’s overall health condition The injection is given intravenously in hospitals or specialized oncology treatment centers. Possible Side Effects Some patients may experience: • Nausea and vomiting • Kidney problems • Fatigue • Hearing issues • Low blood cell counts • Loss of appetite Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Protect from light • Keep in a cool and dry place • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology — Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Celplat 50mg (Cisplatin) Injection Celplat 50 mg Injection contains Cisplatin, a chemotherapy medicine widely used for the treatment of several types of cancers. Cisplatin belongs to the class of medicines known as platinum-based anticancer agents, which work by damaging the DNA of cancer cells and preventing their growth and multiplication. Cisplatin injections are commonly administered in hospitals or oncology treatment centers under the supervision of qualified healthcare professionals. Ernest Oncology supplies Celplat 50mg (Cisplatin) Injection worldwide with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Celplat Injection Generic Name: Cisplatin Strength: 50mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Platinum-Based Chemotherapy Packaging Type: Vial Route of Administration: Intravenous (IV) Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Celplat 50mg Injection Celplat (Cisplatin) Injection is used in the treatment of: • Testicular Cancer • Ovarian Cancer • Bladder Cancer • Lung Cancer • Head and Neck Cancer • Cervical Cancer It is often used in combination with other chemotherapy medicines as part of cancer treatment protocols. How Celplat Injection Works Cisplatin works by binding to the DNA of cancer cells, causing damage that prevents them from dividing and multiplying. This helps slow down or stop the growth of cancer cells in the body. Administration Celplat 50mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Patient’s body weight • Type and stage of cancer • Treatment protocol • Patient’s overall medical condition The injection is administered intravenously in hospitals or specialized oncology treatment centers. Possible Side Effects Some patients may experience: • Nausea and vomiting • Kidney toxicity • Hearing problems • Fatigue • Low blood cell counts • Loss of appetite Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Protect from light • Keep in a cool and dry place • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Ifosfamide Injection (500 mg, 1 g, 2 g) is a widely used cytotoxic medicine from the oxazaphosphorine group, indicated mainly for solid tumors and hematologic malignancies. Key strengths for procurement pages Ifosfamide Injection 500 mg Ifosfamide Injection 1 g Ifosfamide Injection 2 g Dosage forms: single‑dose vials, multi‑strength portfolio (500 mg, 1 g, 2 g) Typical pack configuration: 1 vial per carton, export‑grade secondary packaging Stability and transport: controlled temperature, light‑protected, compliant with standard cold‑chain or ambient logistics according to product specification Provide detailed specification sheets and COAs for regulatory authorities and institutional buyers to support product registration and tender submissions. Indications and Clinical Use Ifosfamide Injection is used in combination chemotherapy regimens for various malignancies, typically in specialist oncology units. As this is a YMYL (Your Money Your Life) pharmaceutical topic, content for public sites should stay informational and avoid therapeutic claims beyond approved labels. Safety, Handling, and Regulatory Compliance Ifosfamide Injection is intended for handling by trained oncology professionals using established safety procedures. International supplies are supported with quality certifications and export documentation based on destination country requirements. Product Specifications Feature Description Generic Name Ifosfamide Dosage Form Sterile Powder for Injection Available Strengths 500 mg, 1 g, 2 g Therapeutic Class Anticancer Medicine Drug Category Alkylating Agent Route Intravenous Administration Prescription Status Hospital Prescription Only Supply Type Bulk Supply & International Export Country of Origin India Clinical Uses: -Soft tissue sarcoma treatment protocols -Bone cancer management -Testicular cancer therapy -Lymphoma treatment plans -Advanced oncology care -Multi-drug chemotherapy programs Wholesale Ifosfamide Injection Supplier Ifosfamide 500 mg for Hospital Procurement Ifosfamide Injection 1 g Bulk Distributor Ifosfamide 2 g Global Pharmaceutical Supply Trusted Oncology Injectable Exporter Cancer Care Injection Supplier Worldwide Sterile Ifosfamide Injection Manufacturer Ifosfamide Oncology Medicine Distributor Bulk Chemotherapy Injection Supplier 🏥 Your Trusted Global Partner for Oncology Pharmaceuticals [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Bulk Supply 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 Frequently Asked Questions 1. Is Ifosfamide Injection supplied for international hospital procurement? Yes. Bulk quantities are available for licensed hospitals, oncology distributors, pharmaceutical importers, and government healthcare organizations. 2. Which strengths of Ifosfamide Injection are available? The commonly supplied strengths include 500 mg, 1 g, and 2 g, depending on manufacturer availability and destination market requirements. 3. How is Ifosfamide Injection administered? It is administered intravenously by qualified healthcare professionals in specialized oncology or hospital settings according to prescribed chemotherapy protocols. 4. What export documents are provided with international orders? Eligible shipments may include COA, COO, CPP (where applicable), commercial invoice, packing list, batch documents, and other regulatory paperwork required by the importing country. 5. Why do international buyers choose Indian exporters for Ifosfamide Injection? Indian pharmaceutical exporters are valued for their ability to provide consistent bulk availability, internationally accepted manufacturing standards, responsive export support, and efficient global distribution networks. This enables hospitals, oncology distributors, and licensed importers to maintain a dependable supply of quality injectable medicines while meeting their procurement and regulatory requirements. Cyclophosphamide Injection Doxorubicin Injection Cisplatin Injection Carboplatin Injection Gemcitabine Injection Etoposide Injection